RELATED CONTENT
Getty Images
News | Radiology Business | November 03, 2020
November 3, 2020 — The Radiological Society of North America (...
Gadolinium contrast agents (GBCAs) are partly retained in the brain, raising safety concerns, as seen in this MRI.
News | Contrast Media | January 17, 2020
January 17, 2020 — Bracco Diagnostics Inc., the U.
Technology | Contrast Media | August 05, 2019
Bracco Diagnostics Inc. announced U.S. Food and Drug Administration (FDA) approval for Varibar Thin Liquid (barium...
Two brain metastases from primary lung cancer are contrast enhanced in the brain of a 61-year-old male. Speakers at AHRA 2019 will state that ProHance and other macrocyclic MR agents present a very low risk to patients. Images courtesy of Bracco
Feature | Contrast Media | July 18, 2019 | By Greg Freiherr
Macrocyclic contrast agents have the best safety profile of all the magnetic resonance (MR) contrast media that are n
News | Radiopharmaceuticals and Tracers | July 01, 2019
Bracco Imaging S.p.A. has signed a definitive agreement to acquire Blue Earth Diagnostics, a molecular imaging company...
News | Radiology Business | June 27, 2019
Blue Earth Diagnostics, a molecular imaging diagnostics company, announced that a definitive agreement has been signe
News | Ultrasound Imaging | September 24, 2018
Physicians and technologists at Children’s Hospital of Philadelphia (CHOP) will be able to conduct research and...
